Soliddd Corp., a New York City-based optical and vision technology company, introduced its SolidddVision smart glasses ...

Astellas Pharma Inc. (ALPMY, ALPMY) announced that the U.S. Food and Drug Administration accepted the revised supplemental New Drug ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Rates of nearsightedness, or myopia, are skyrocketing in kids—and scientists say it has to do with how little time they’re ...

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...

Macular degeneration is a leading cause of vision loss, especially in people over the age of 50. It affects the macula, a ...

CES 2025 is just around the corner, and our favorite companies are showing off their latest and greatest tech early. One of those companies is Solidd.

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.

Headset designed for healthcare professionals to debut at Pepcom at CES on January 7 in Las Vegas. COLORADO SPRINGS, Colo.

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

Eye diseases are conditions that affect the eyes, leading to vision impairment or loss. Common types include cataracts, glaucoma, macular degeneration ... the demand for advanced ocular implants rises ...